Alto Neuroscience (ANRO) Change in Cash (2023 - 2026)

Alto Neuroscience has disclosed Change in Cash across 4 years of filings, most recently posting $87.3 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $87.3 million, up 1267.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.0 million (up 330.75% YoY), and the FY2025 annual result was $8.3 million, down 90.42% from the prior year.
• Change in Cash came in at $87.3 million for Q1 2026 at Alto Neuroscience, up from $38.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $123.3 million in Q1 2024 to a low of -$13.5 million in Q4 2024.
• The 4-year median for Change in Cash is -$7.5 million (2025), against an average of $16.6 million.
• Across the five-year window, Change in Cash sank 143.1% in 2024 and jumped 1267.6% in 2026, its largest moves.
• Alto Neuroscience's Change in Cash stood at $31.3 million in 2023, then slumped by 143.1% to -$13.5 million in 2024, then jumped by 387.02% to $38.7 million in 2025, then jumped by 125.71% to $87.3 million in 2026.
• The last three Change in Cash figures came in at $87.3 million (Q1 2026), $38.7 million (Q4 2025), and -$9.8 million (Q3 2025), per Business Quant data.